1 中华医学会神经病学分会脑血管病学组急性缺血性

脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治

指南2010[J]. 中华神经科杂志，2010，43：146-153.

2 Gao S，Wang YJ，Xu AD，et al. Chinese Ischemic

Stroke Subclassification[J]. Front Neurol，2011，2：1-5.

3 中华医学会心血管病学分会，中华心血管病杂志编辑

委员会. 不稳定性心绞痛和非ST段抬高心肌梗死诊

断与治疗指南[J]. 中华心血管病杂志，2007，35：295-

304.

4 Mehran R，Rao SV，Bhatt DL，et al. Standardized

bleeding definitions for cardiovascular clinical trials：a

consensus report from the bleeding academic research

consortium[J]. Circulation，2011，123：2736-2747.

5 Hochholzer W，Trenk D，Fromm MF，et al. Impact of

cytochrome P450 2C19 loss-of-function polymorphism

and of major demographic characteristics on residual

platelet function after loading and maintenance treatment

with clopidogrel in patients undergoing elective coronary

stent placement[J]. J Am Coll Cardiol，2010 Jun 1，55：

2427-2434.

6 Holmes DR Jr，Dehmer GJ，Kaul S，et al. ACCF/AHA

Clopidogrel clinical alert：approaches to the FDA

"boxed warning"：a report of the American College of

Cardiology Foundation Task Force on Clinical Expert

Consensus Documents and the American Heart

Association[J]. Circulation，2010，122：537-557.

7 Xiao ZS，Goldstein JA，Xie HG，et al. Differences

in the incidence of the CYP2C19 polymorphism

affecting the s-mephenytoin phenotype in Chinese

Han and Bai populations and identification of a new

rare CYP2C19 mutant allele[J]. J Pharmacol Exp Ther，

1997，281：604-609.

8 De Morais SM，Wilkinson GR，Blaisdell J，et al.

Identification of a new genetic defect responsible for

the polymorphism of (S)-mephenytoin metabolism in

Japanese[J]. Mol Pharmacol，1994，46：594-598.

9 Simon T，Verstuyf t C，Mary-Krause M，et al.

Genetic determinants of response to clopidogrel and

cardiovascular events[J]. N Engl J Med，2009，360：

363-375.

10 Wang Y，Pan Y，Zhao X，et al. Clopidogrel with

Aspirin in Acute Minor Stroke or Transient Ischemic

Attack (CHANCE) Trial：One-year outcomes[J].

Circulation，2015，132：40-46.

11 Saw J，Brennan DM，Steinhubl SR，et al. Lack of

evidenceof a clopidogrel statin interaction in the

CHARISMA trial[J]. J Am Coll Cardiol，2007，50：

291-295.

12 Wenaweser P，Eshtehardi P，Abrecht L，et al. A

randomised determination of t he effect of fluvastatin

and atorvastatin on top of dual antiplatelet treatment

on platelet aggregation after implantation of coronary

drug-eluting stents. The EFA-Trial[J]. Thromb

Haemost，2010，104：554-562.

13 Bliden KP，Dichiara J，Lawal L，et al. The association

of cigarette smoking with enhanced platelet inhibition

by clopidogrel[J]. J Am Coll Cardiol，2008，52：531-

533.

14 Witt BJ，Ballman KV，Brown RD Jr，et al. The

incidence of stroke after myocardial infarction：a

meta-analysis[J]. AM J Med，2006，119：354. e1-9.

15 Depta JP，Fowler J，Novak E，et al. Clinical outcomes

using a platelet function-guided approach for

secondary prevention in patients with ischemic stroke

or transient ischemic attack[J]. Stroke，2012，43：

2376-2381.

16 Ke r n a n WN，Ovbiagele B，Black HR，e t a l .

Guidelines for the prevention of stroke in patients

with stroke and transient ischemic attack：a guideline

for health care professionals from the American Heart

Association/American Stroke Association[J]. Stroke，

2014，45：2160-2236.

17 中华医学会神经病分会，中华医学会神经病学分会脑

血管病学组. 中国缺血性脑卒中和短暂性脑缺血发

作二级预防指南2014[J].中华神经科杂志，2015，48：

258-273.